Literature DB >> 16239529

Influence of CR3 (CD11b/CD18) expression on phagocytosis of Bordetella pertussis by human neutrophils.

Paula S Mobberley-Schuman1, Alison A Weiss.   

Abstract

CR3 (CD11b/CD18) is expressed on neutrophils, and the engagement of CR3 can promote phagocytosis. CR3 serves as the receptor for the Bordetella pertussis adhesin filamentous hemagglutinin (FHA) and for the adenylate cyclase toxin (ACT), which blocks neutrophil function. The influence of CR3, FHA, and ACT on the phagocytosis of B. pertussis by human neutrophils was examined. The surface expression and function of CR3 are regulated. Tumor necrosis factor alpha (TNF-alpha) and gamma interferon (IFN-gamma) increased CR3 surface expression, but only TNF-alpha increased the ability of neutrophils to phagocytose B. pertussis, suggesting that elevated CR3 expression alone is not sufficient to promote phagocytosis. Purified FHA and pertussis toxin also increased the surface expression of CR3 on neutrophils, while ACT and the B subunit of pertussis toxin did not affect CR3 expression. FHA-mediated attachment to CR3 can lead to phagocytosis, especially in the absence of ACT. FHA mutants failed to attach and were not phagocytosed by neutrophils. Similarly, an antibody to CR3 blocked both attachment and phagocytosis. The addition of exogenous FHA enhanced the attachment and phagocytosis of wild-type B. pertussis and FHA mutants. Mutants lacking the SphB1 protease, which cleaves FHA and allows the release of FHA from the bacterial surface, were phagocytosed more efficiently than wild-type bacteria. ACT mutants were efficiently phagocytosed, but wild-type B. pertussis or ACT mutants plus exogenous ACT resisted phagocytosis. These studies suggest that the activation and surface expression of CR3, FHA expression, and the efficiency of ACT internalization all influence whether B. pertussis will be phagocytosed and ultimately killed by neutrophils.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16239529      PMCID: PMC1273866          DOI: 10.1128/IAI.73.11.7317-7323.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  Bordetella pertussis virulence factors affect phagocytosis by human neutrophils.

Authors:  C L Weingart; A A Weiss
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

2.  Characterization of bactericidal immune responses following vaccination with acellular pertussis vaccines in adults.

Authors:  C L Weingart; W A Keitel; K M Edwards; A A Weiss
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

3.  Neutralizing antibodies to adenylate cyclase toxin promote phagocytosis of Bordetella pertussis by human neutrophils.

Authors:  C L Weingart; P S Mobberley-Schuman; E L Hewlett; M C Gray; A A Weiss
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

4.  Subtilisin-like autotransporter serves as maturation protease in a bacterial secretion pathway.

Authors:  L Coutte; R Antoine; H Drobecq; C Locht; F Jacob-Dubuisson
Journal:  EMBO J       Date:  2001-09-17       Impact factor: 11.598

5.  Immunoglobulin A-mediated protection against Bordetella pertussis infection.

Authors:  S M Hellwig; A B van Spriel; J F Schellekens; F R Mooi; J G van de Winkel
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

6.  Role of the Bordetella pertussis P.69/pertactin protein and the P.69/pertactin RGD motif in the adherence to and invasion of mammalian cells.

Authors:  P Everest; J Li; G Douce; I Charles; J De Azavedo; S Chatfield; G Dougan; M Roberts
Journal:  Microbiology       Date:  1996-11       Impact factor: 2.777

7.  Proinflammatory and proapoptotic activities associated with Bordetella pertussis filamentous hemagglutinin.

Authors:  T Abramson; H Kedem; D A Relman
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

8.  Tumour necrosis factor-alpha potentiates CR3-induced respiratory burst by activating p38 MAP kinase in human neutrophils.

Authors:  M Forsberg; R Löfgren; L Zheng; O Stendahl
Journal:  Immunology       Date:  2001-08       Impact factor: 7.397

9.  Exploiting type 3 complement receptor for TNF-alpha suppression, immune evasion, and progressive pulmonary fungal infection.

Authors:  T Tristan Brandhorst; Marcel Wüthrich; Bea Finkel-Jimenez; Thomas Warner; Bruce S Klein
Journal:  J Immunol       Date:  2004-12-15       Impact factor: 5.422

10.  The adenylate cyclase toxin of Bordetella pertussis binds to target cells via the alpha(M)beta(2) integrin (CD11b/CD18).

Authors:  P Guermonprez; N Khelef; E Blouin; P Rieu; P Ricciardi-Castagnoli; N Guiso; D Ladant; C Leclerc
Journal:  J Exp Med       Date:  2001-05-07       Impact factor: 14.307

View more
  28 in total

1.  Opsonophagocytic activity and other serological indications of Bordetella pertussis infection in military recruits in Norway.

Authors:  Audun Aase; Tove Karin Herstad; Samuel Merino; Kari Torkildsen Brandsdal; Bjørn Peter Berdal; Erja M Aleksandersen; Ingeborg S Aaberge
Journal:  Clin Vaccine Immunol       Date:  2007-05-16

2.  Role of HrpA in biofilm formation of Neisseria meningitidis and regulation of the hrpBAS transcripts.

Authors:  R Brock Neil; Michael A Apicella
Journal:  Infect Immun       Date:  2009-03-16       Impact factor: 3.441

3.  Intracellular trafficking of Bordetella pertussis in human macrophages.

Authors:  Yanina A Lamberti; Jimena Alvarez Hayes; Maria L Perez Vidakovics; Eric T Harvill; Maria Eugenia Rodriguez
Journal:  Infect Immun       Date:  2010-01-11       Impact factor: 3.441

4.  Bordetella pertussis proteins dominating the major histocompatibility complex class II-presented epitope repertoire in human monocyte-derived dendritic cells.

Authors:  Rachel M Stenger; Hugo D Meiring; Betsy Kuipers; Martien Poelen; Jacqueline A M van Gaans-van den Brink; Claire J P Boog; Ad P J M de Jong; Cécile A C M van Els
Journal:  Clin Vaccine Immunol       Date:  2014-03-05

Review 5.  Pertussis pathogenesis--what we know and what we don't know.

Authors:  Erik L Hewlett; Drusilla L Burns; Peggy A Cotter; Eric T Harvill; Tod J Merkel; Conrad P Quinn; E Scott Stibitz
Journal:  J Infect Dis       Date:  2014-04-01       Impact factor: 5.226

Review 6.  Pertussis toxin and adenylate cyclase toxin: key virulence factors of Bordetella pertussis and cell biology tools.

Authors:  Nicholas H Carbonetti
Journal:  Future Microbiol       Date:  2010-03       Impact factor: 3.165

7.  XacFhaB adhesin, an important Xanthomonas citri ssp. citri virulence factor, is recognized as a pathogen-associated molecular pattern.

Authors:  Betiana S Garavaglia; Tamara Zimaro; Luciano A Abriata; Jorgelina Ottado; Natalia Gottig
Journal:  Mol Plant Pathol       Date:  2016-06-09       Impact factor: 5.663

8.  Comparison of capillary and venous blood in the analysis of concentration and function of leucocyte sub-populations.

Authors:  Elisa F D Canetti; J Keane; C P McLellan; A B Gray
Journal:  Eur J Appl Physiol       Date:  2016-06-15       Impact factor: 3.078

9.  Quantification of the adenylate cyclase toxin of Bordetella pertussis in vitro and during respiratory infection.

Authors:  Joshua C Eby; Mary C Gray; Jason M Warfel; Christopher D Paddock; Tara F Jones; Shandra R Day; James Bowden; Melinda D Poulter; Gina M Donato; Tod J Merkel; Erik L Hewlett
Journal:  Infect Immun       Date:  2013-02-19       Impact factor: 3.441

Review 10.  Pathogenesis of mucosal biofilm infections: challenges and progress.

Authors:  Anna Dongari-Bagtzoglou
Journal:  Expert Rev Anti Infect Ther       Date:  2008-04       Impact factor: 5.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.